Gynositol
Commercial- Indications
- Polycystic ovary syndrome
Company intelligence / Profile preview
Gynov
Bordeaux, Nouvelle-Aquitaine, Francednb.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Gynov markets innovative nutritional supplements focused on women's health in nearly 30 countries through agreements with pharmaceutical companies
- Therapeutic areas
- Women's Health
- Modalities
- Nutritional supplementsFood for Special Medical Purposes (DADFMS)medical devices
- Industry
- Food & Nutrition
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Pharmaceutical companies for distribution (specific names not mentioned)
Beyond the preview
Go deeper on Gynov.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gynov.